Error loading player: No playable sources found
T101g
Panel Questions – ICH Guideline Updates
Date
May 12, 2020
This product is not available for individual purchase, but it is available as part of the following products:
The purpose of the CMC Strategy Forum Europe 2020 is to offer a blend of topics that characterize the challenges facing the biotechnology industry in the next decade…
Chairs
European Medicines Agency (EMA)
F. Hoffmann-La Roche Ltd.
Pfizer Ireland Pharmaceuticals Limited
Panelists
Danish Medicines Agency
Janssen Pharmaceutical R&D, LLC
HPRA-Health Products Regulatory Authority
Pfizer Pharma GmbH
European Medicines Agency (EMA
Tracks
Related Products
Analytical Procedure Validation and Development – Status Update
The new ICH Q14 guideline is proposed to harmonise the scientific approaches to analytical procedure development and provide the principles relating to the dossier description…
Drug Product Continuous Manufacturing - Daurismo™ Case Study
Continuous Manufacturing is the future standard for solid oral dosage forms. The greater process understanding, and control is redefining how drugs are produced. The faster, more precise and reliable manufacturing approach is enabling accelerated development…
Overview of the January 2020 CASSS Sharing Science Solutions Workshop on Established Conditions
The ICH Q12 Guideline on Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management and its Annexes reached Step 4 of the ICH Process at the ICH meeting in Singapore on 21 November 2019…
KBI Biopharma Inc. Vendor Showcase
KBI Biopharma is a leading contract development and manufacturing organization for the biopharmaceutical industry. We accelerate and optimize drug development and manufacturing programs for our client partners…
